Important: New Login Process
We've updated our access and security system. The first time you log in, enter your work email, and we'll guide you through the process.
- If your organization uses Single Sign-On (SSO), you will be redirected to your company's login portal.
- If you log in with a username and password, you will be prompted to set a new password before accessing your account.
Go to the Login Page to get started.
We appreciate your cooperation during this transition. If you need assistance, please call +1 650-552-4224 or email support@biocentury.com.
- Company Profiles
- Target Profiles
- Product Profiles
Explore BCIQ profiles by entering a company name.
Big Health
Headquarters: San Francisco, CA, United States of America
Website: http://www.bighealth.com
Year Founded: 2010
Status: Private
BioCentury | Jan 13, 2023
Management Tracks
Richardson becomes CSO at Mallinckrodt
Plus: XtalPi hires new COO for U.S. operations, and updates from Jupiter, Big Health and Edelman Global
BioCentury | Feb 4, 2022
Management Tracks
COO Metzger now CEO at Syndax as Morrison shifts to R&D
Plus Dubin named president of Takeda’s vaccine unit and updates from Mizuho, Quest and more
BioCentury | Apr 16, 2021
Politics, Policy & Law
Pandemic pain: how COVID-19 has devastated patient groups
Patient groups that are an essential part of the life sciences ecosystem are suffering from increased demands and decreased funding
BioCentury | Jan 8, 2021
Product Development
Caplan sees a host of bioethical turning points coming out of the pandemic
Bioethicist Arthur Caplan on how the post-pandemic world will see changes from patient consent to DSMBs to data dissemination
BioCentury | Aug 12, 2020
Product Development
Aug. 11 Quick Takes: BMS hits, Genentech misses; plus JW-Lyell, CStone, Big Health
Opdivo clears Phase III hurdles in gastric, esophageal cancers Opdivo nivolumab from Bristol Myers Squibb Co. (NYSE:BMY) plus chemotherapy led to a survival benefit compared with
BioCentury | Aug 31, 2019
Product Development
Rethinking first principles
Back to School Part 4: Digital health will call for a new set of first principles for clinical development
BioCentury | Aug 31, 2019
Product Development
Digital health: payers are figuring out what it’s worth
Back to School 2019: The first payer models for digital therapeutics are coming into view next year
BioCentury | Jun 13, 2019
Company News
June 12 Company Quick Takes: Macao approves Zai's Zejula; plus Roche, NIH, CVS and Dassault-Medidata
Items per page:
1 - 9 of 9